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Abstract: Breast cancer surgery significantly affects the shoulder’s range of motion (ROM) and
strength. However, the extent of shoulder impairment, as well as patterns of recovery immediately
after surgery, is not fully understood. Therefore, we aimed to investigate shoulder ROM and
strength during the early recovery phase after surgery. Thirty-two breast cancer patients were
observed five times: the day before surgery, discharge day (postoperative day 1 (POD1) or (POD2)),
first outpatient visit (POD7–10), second outpatient visit (POD14–20), and third outpatient visit
(POD21–30). We assessed shoulder passive ROM and strength for both affected and unaffected arms
at each observation. ROM decreased in both affected and unaffected sides post-surgery. ROM on
the affected side did not recover to the pre-surgery level until the third outpatient visit (POD24). In
contrast, the ROM on the unaffected side recovered to the pre-surgery level by the first outpatient
visit (POD10). The shoulder strength of both arms declined and did not recover to pre-surgery levels.
Shoulder strength in the affected arm significantly decreased immediately after surgery (52.9% of
the pre-surgery levels) and did not recover until the third outpatient visit (62.5% of the pre-surgery
levels), whereas that in the unaffected arm decreased gradually (83.1 ± 2.3 at POD 1 and 78.9 ± 2.9
at POD 24). Descriptively, patterns of recovery in ROM may vary according to types of surgery while
patterns of recovery in shoulder strength did not: shoulder strength significantly decreased and
did not recover notably regardless of types of surgery. Both shoulder ROM and strength reduced
during the early recovery phase after breast cancer surgery regardless of types of surgery, although
the degree of reduction was greater in shoulder strength than ROM. Our findings suggest that
rehabilitation exercises should be implemented in both upper limbs.
Keywords: breast cancer; mastectomy; breast-conserving surgery; range of motion; strength
1. Introduction
A surgical approach is the primary step of breast cancer treatment, which aims to
completely remove the entire tumor [1]. Even though surgical techniques have improved
significantly, breast cancer patients still experience adverse effects, including reduced
shoulder range of motion (ROM), impaired upper body strength, chronic pain, and sensory
disturbances [2–4].
One of the most common complications after breast cancer surgery is a functional
limitation of the upper body. Up to 67% of breast cancer patients experience arm or
shoulder impairment, including pain, numbness, loss of strength, and reduced ROM, after
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surgery [2,5]. Although most breast cancer patients experience some degree of discomfort
and functional limitation, the degree of morbidities after breast cancer surgery varies
according to surgical methods. Patients undergoing a mastectomy experience 5.7 times
(odds ratio (OR) 5.7, 95% confidence interval (CI) 1.03–31.2) greater postoperative shoulder
problems than patients undergoing breast-conserving surgery [5]. Axillary dissection also
significantly contributes to the reduction in arm mobility compared with sentinel lymph
node biopsy (SLNB) [6]. Regardless of the surgical method, most breast cancer patients
experience chronic arm or shoulder discomfort, which lasts up to 3 years after surgery [5].
Shoulder problems in breast cancer patients affect their daily activities, such as pulling
a sweater overhead, fastening a bra, zipping up a back zipper, reaching overhead, and
carrying heavy bags [7]. A systematic review suggested that at least 150◦ elbow flexion
and 130◦ shoulder flexion and abduction are required to perform personal care, eating, and
drinking [8]. However, many breast cancer patients are unable to achieve 150◦ elbow flexion
and 130◦ of shoulder flexion even after several years post-surgery [9,10]. Additionally,
shoulder morbidities, including pain, loss of strength, and limited shoulder ROM, lead to a
declining quality of life in breast cancer patients after surgery [3,11]. Consequently, only
59% of breast cancer survivors returned to work, and even among those who returned to
their workplace, a substantial percentage of them were not able to work full time because
of physical conditions, including these shoulder problems [12]. Therefore, rehabilitation
after breast cancer surgery is essential to improve patients’ quality of life and increase the
return to work rate.
Breast cancer patients experience the most frequent and significant shoulder morbidi-
ties immediately after surgery. Although studies have reported the long-term consequences
of breast cancer surgery in the upper body, shoulder ROM and strength during the early
phase of rehabilitation have not been studied. More importantly, variances in shoulder
ROM and strength according to the types of surgery are not yet fully understood.
Therefore, the purpose of the current study is to examine the shoulder ROM and
strength in both the affected and unaffected arm after breast cancer surgery for up to
4 weeks.
2. Materials and Methods
2.1. Participants
Thirty-two breast cancer patients were recruited from Severance Hospital, Yonsei
University Health System, Seoul, Korea, from 14 February to 2 November 2019. Eligibility
criteria included the following: (1) age between 19 and 70 years; (2) histologically confirmed
stage <IV breast cancer; (3) ability to understand and provide written informed consent in
Korean. We excluded (1) patients who were scheduled bilateral breast surgery, (2) breast
reconstruction surgery, or (3) existing evidence of recurrent or metastatic diseases. This
study was approved by the Institutional Review Board of Severance Hospital (IRB No.
4-2018-1094), and all participants provided written informed consent.
2.2. Study Designs
This study was a prospective observational study. Eligible participants were evaluated
for all assessment variables five times over the span of a month (day before surgery, hospital
discharge (postoperative day 1, POD1), first outpatient visit (POD7–10), second outpatient
visit (POD14–20), and third outpatient visit (POD21–30).
2.3. Outcome Measures
All measurements were performed in duplicate by a single investigator, on both
the affected and unaffected upper limbs. If the difference between the first and second
measurements was >5%, a third measurement was performed, and the closest two values
were averaged.
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2.3.1. Range of Motion
In each participant, three shoulder movements (flexion, abduction, and extension) of
passive range of motion were measured using a digital goniometer (Goniometer bending
iron 29-5900, Pakistan). Flexion and abduction were evaluated in the supine position and
extension was measured in standing position [13].
2.3.2. Shoulder Strength
The shoulder muscle strength, measured in pounds (lb), was determined using a
handheld dynamometer (J-tech Medical Industries Inc., Heber City, UT, USA). Strength
peak muscle force was measured using maximal voluntary isometric contraction (MVIC)
in flexion, abduction, extension [14].
2.3.3. Shoulder Function Score
Shoulder function score was calculated for ease of interpretation of shoulder ROM
and strength. It was converted to 100 scales for each measurement relative to the baseline
and each assessment summed ROM (flexion+ extension+ abduction) and strength value
(flexion+ extension+ abduction) was converted to a standard 100-point scale.
2.4. Statistical Analysis
We analyzed the entire data using a parametric method after testing for the normality
of distribution using the Shapiro–Wilk test. Descriptive analyses were used to evaluate
demographic information, baseline body composition, and medical information. Changes
in shoulder ROM, strength, and shoulder function score were assessed for both the affected
and unaffected sides using univariate repeated measures of ANOVA (RM-ANOVA). When
the difference was statistically significant, we conducted a post-hoc comparison between
the baseline evaluation and each measurement point. The post-hoc test was performed
using the paired t-test with Bonferroni’s correction [15]. After baseline value adjustment,
analysis of covariance was used to compare differences between the affected and unaffected
arms. RM-ANOVA was conducted to investigate the pattern of changes according to the
surgical type in shoulder ROM, strength, and shoulder function score over time and groups.
All statistical analyses were performed using SPSS version 25 software (IBM Corp., Armonk,
NY, USA), and statistical significance was at p < 0.05.
3. Results
3.1. Participants’ Characteristics
Thirty-two patients (15 total mastectomy (TM), 17 partial mastectomy (PM)) diagnosed
with breast cancer stage 0–3 participated in this study. The mean age of participants was
52.3 ± 7.6 years, and the mean body mass index was 24.6 ± 2.9 kg/m2. Of the participants,
46.9% underwent neoadjuvant chemotherapy (Table 1).
3.2. Change in Shoulder Range of Motion (from Pre-Surgery to 4-Week Post-Surgery)
The ROM of flexion and extension on the affected side was significantly reduced
immediately after surgery. Although the ROM slowly improved, it remained considerably
below baseline levels (flexion −36.1% to −18.2%, extension −27.2% to −16%). Notably, the
ROM of shoulder abduction significantly decreased immediately after surgery (−46.7%
at POD1) and barely recovered until the third outpatient visit (−45.7% at POD24) to
the baseline level (Table 2). In the unaffected side, the only significant difference in
ROM occurred in flexion and abduction on POD1, compared with the baseline ROM.
After surgery, the ROM between the affected and unaffected arms exhibited a significant
difference at all measurement points (Table 2).
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Table 1. Participants’ characteristics.






(N = 9) P
Age (years) 50.0 ± 11.1 53.6 ± 6.7 52.6 ± 7.9 52.8 ± 5.3 0.8
Weight (kg) 61.7 ± 8.3 66.5 ± 9.7 63.0 ± 7.9 58.4 ± 6.3 0.3
BMI (kg/m2) 23.3 ± 2.4 25.9 ± 3.7 25.5 ± 2.9 23.7 ± 1.9 0.2
Muscle mass (kg) 23.0 ± 2.3 23.6 ± 2.7 22.4 ± 2.3 20.8 ± 2.1 0.1
Fat (%) 30.1 ± 4.6 33.5 ± 5.5 33.0 ± 6.0 33.6 ± 6.6 0.6
Stage (n, %)
0 0 3 (37.5%) 2 (25%) 4 (44.4%)
0.6
1 1 (14.3%) 3 (37.5%) 2 (25%) 5 (55.6%)
2 3 (42.9%) 2 (25%) 3 (37.5%) 0
3 3 (42.9%) 0 1 (12.5%) 0
Surgery site (n, %)
Right 5 (71.4%) 4 (50%) 4 (50%) 6 (66.7%) 0.8
Dominant arm 5 (71.4%) 5 (62.5%) 4 (50%) 6 (66.7%) 0.8
Dissected LNs 18 (9–25) 7 (3–13) 17.5 (10–26) 9 (5–12) <0.001
Surgery duration (min)
108.9 ± 21.4 95 ± 16.1 122.3 ± 59.4 93.4 ± 40.0 0.5
Drainage removal day (n, %)
1st outpatient visit
(POD 10) 1 (14.3%) 1 (12.5%) 0 3 (33.3%)
0.32nd outpatient
visit (POD 17) 6 (85.7%) 4 (50%) 4 (50%) 4 (44.4%)
3rd outpatient visit
(POD 24) 0 3 (37.5%) 3 (37.5%) 1 (11.1%)
4th outpatient visit 0 0 1 (12.5%) 1 (11.1%)
Neoadjuvant chemotherapy
Yes 6 (85.7%) 1 (12.5%) 7 (87.5%) 1 (11.1%) <0.001
Values are presented as Mean ± SD or n (%), Dissected LNs are showed median (minimum to maximum range). Abbreviation: Total
mastectomy with axillary lymph node dissection; TM with ALND, Total mastectomy with sentinel node biopsy; TM with SLNB, Partial
mastectomy with axillary node dissection; PM with ALND, Partial mastectomy with sentinel node biopsy; PM with SLNB, Lymph Nodes;
LNs, Postoperative Date; POD.
When ROM was examined according to the surgical types, the greatest reduction in the
affected side occurred in patients who underwent TM with axillary lymph node dissection
(ALND) (flexion −48.8% to −23.5%, abduction −61.1% to −51.2%). The smallest reduction
was observed in those who underwent PM with SLNB (PM&SLNB; flexion −19.9% to
−8.1%, abduction −29.5% to −27.2%). However, no significant difference existed among
the groups and time effects (Figure 1).
3.3. Change in Shoulder Strength (from Pre-Surgery to 4-Week Post-Surgery)
Shoulder strength of the affected side was significantly reduced immediately after
surgery (reduction rate relative to baseline: flexion −50.6%, extension −44.8%, abduction
−49.1%, horizontal adduction −41.3%, and horizontal abduction −36.8%) and slowly
recovered in the 24 days after surgery. In contrast, shoulder strength of the unaffected
side gradually decreased over time. Except for shoulder extension on POD10, significant
differences between the affected and unaffected arms were observed at all measurement
points after surgery (Table 3). A similar pattern of reduction was observed in the shoulder
strength of the affected side regardless of the surgical methods (Figure 2).
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Table 2. Change of shoulder range of motion (pre-surgery to 4 weeks post-surgery).









Shoulder range of motion
Flexion
Affected side (n = 29) 174.0 ± 1.3 111.1 ± 8.6 **+ 132.5 ± 4.7 **+ 137.5 ± 4.2 **+ 142.3 ± 4.6 **+ <0.001 <0.001 0.005 0.071 0.01
Unaffected side (n = 31) 176.4 ± 0.8 161.7 ± 3.6 ** 174.4 ± 0.7 174.7 ± 0.9 174.9 ± 0.7 0.02 <0.001 0.001 0.765 0.625
Abduction
Affected side (n = 30) 169.1 ± 2.8 90.2 ± 7.1 **+ 84.1 ± 4.5 **+ 87.9 ± 5.7 **+ 91.8 ± 6.1 **+ <0.001 <0.001 0.386 0.437 0.164
Unaffected side (n = 31) 170.2 ± 1.9 153.7 ± 4.4 * 166.0 ± 2.4 169.0 ± 2.1 171.2 ± 2.1 0.004 0.001 0.0.21 0.197 0.05
Extension
Affected side (n = 30) 47.4 ± 1.1 34.5 ± 2.1 **+ 37.3 ± 1.6 **+ 38.1 ± 1.8 **+ 39.8 ± 1.6 **+ <0.001 <0.001 0.200 0.642 0.101
Unaffected side (n = 31) 46.0 ± 1.2 44.7 ± 1.8 44.1 ± 1.5 43.8 ± 1.6 45.8 ± 1.2 0.36 0.568 0.788 0.859 0.133
Values are presented as mean ± standard error (SE). Postoperative Date; POD, p # represent overall differences according to time as determined using the repeated measures of ANOVA, * p < 0.01 vs. Baseline,
** p < 0.001 vs. Baseline, + p < 0.01 between the affected and unaffected side (POD1 to POD 24 adjusted for Baseline value).
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Table 3. Change of shoulder strength (pre-surgery to 4 weeks post-surgery).











Affected side (n = 31) 16.0 ± 0.9 7.9 ± 0.8 **+ 7.8 ± 0.7 **+ 8.8 ± 0.7 **+ 8.9 ± 0.6 **+ <0.001 <0.001 0.890 0.017 0.850
Unaffected side (n = 31) 15.5 ± 0.8 12.7 ± 0.9 ** 11.8 ± 0.8 ** 11.7 ± 0.6 ** 11.0 ± 0.5 ** <0.001 <0.001 0.173 0.866 0.071
Abduction
Affected side (n = 31) 15.5 ± 1.0 7.0 ± 0.6 **+ 7.0 ± 0.6 **+ 7.8 ± 0.7 **+ 7.6 ± 0.5 **+ <0.001 <0.001 0.992 0.009 0.422
Unaffected side (n = 31) 15.0 ± 0.9 12.1 ± 0.9 ** 11.2 ± 0.7 ** 11.1 ± 0.6 ** 11.0 ± 0.6 ** <0.001 <0.001 0.181 0.823 0.607
Extension
Affected side (n = 31) 22.3 ± 1.0 12.3 ± 1.0 **+ 15.1 ± 1.0 ** 15.5 ± 0.8 **+ 16.1 ± 0.7 **+ <0.001 <0.001 0.001 0.426 0.521
Unaffected side (n = 31) 22.7 ± 1.2 17.6 ± 1.1 ** 17.4 ± 1.0 ** 19.0 ± 0.9 ** 18.0 ± 0.8 ** <0.001 <0.001 0.783 0.047 0.147
Horizontal adduction
Affected side (n = 31) 19.6 ± 1.0 11.5 ± 1.1 **+ 11.3 ± 1.0 **+ 12.3 ± 0.9 **+ 12.9 ± 1.0 **+ <0.001 <0.001 0.754 0.073 0.355
Unaffected side (n = 31) 19.5 ± 1.1 16.4 ± 1.0 ** 16.7 ± 1.2 * 16.7 ± 0.9 * 15.3 ± 0.8 ** <0.001 <0.001 0.649 0.979 0.006
Horizontal abduction
Affected side (n = 30) 19.3 ± 1.2 12.2 ± 1.1 **+ 11.5 ± 1.0 **+ 12.7 ± 0.8 **+ 12.0 ± 0.8 **+ <0.001 <0.001 0.312 0.066 0.263
Unaffected side (n = 31) 19.2 ± 1.0 17.4 ± 1.1 15.9 ± 1.2 * 15.6 ± 0.8 ** 14.9 ± 0.6 ** <0.001 0.020 0.025 0.771 0.095
Values are presented as mean ± standard error (SE). Postoperative Date; POD, P # represent overall differences according to time as determined using the repeated measures of ANOVA, * p < 0.01 vs. Baseline,
** p < 0.001 vs. Baseline, + p <0.01 between the affected and unaffected side (POD1 to POD 24 adjusted for Baseline value).




Figure 1. The changes in the shoulder range of motion after breast surgery according to 
the surgery type in the affected side (descriptive). P: the repeated measure of ANOVA 
analysis (group time interaction). Abbreviation: Total mastectomy with axillary lymph 
node dissection; TM&ALND, Total mastectomy with sentinel node biopsy; TM&SLNB, 
Partial mastectomy with axillary node dissection; PM&ALND, Partial mastectomy with 
sentinel node biopsy; PM&SLNB, Postoperative day: POD 
Figure 1. The changes in the shoulder range of motion after breast surgery according to the surgery
type in the affected side (descriptive). P: the repeated measure of ANOVA analysis (group time
interaction). Abbreviation: T tal mast ctomy with axillary ly ph node dissection; TM&ALND, Total
mastectomy with sentinel node biopsy; TM&SLNB, Par ial mast ctomy with axillary node dissection;
PM&ALND, Partial mastectomy with sentinel node biopsy; PM&SLNB, Postoperative day: POD.
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3.4. Change in Shoulder Function (from Pre-Surgery to 4-Week Post-Surgery) 
On the affected arm, both shoulder ROM and strength scores significantly decreased 
compared to their pre-surgery levels and did not fully recover until 4 weeks after surgery 
(Table 4). On the unaffected arm, the ROM score only decreased on POD1 compared to its 
pre-surgery level. Conversely, the shoulder strength of the unaffected arm significantly 
reduced throughout the study period compared to its pre-surgery level. When shoulder 
recovery patterns were analyzed by age, body mass index (BMI), and the number of 
lymph nodes removed, recovery patterns did not differ by BMI and number lymph node 
recovery: only age (under 55 age vs. over 55 age) showed a difference in the recovery of 
the ROM score of the affected side (P for time = 0.04; Supplementary Figures S1 and S2). 
Figure 2. The changes in the shoulder strength after breast surgery according to the surgery type in
the affected si ( escriptive). P: the repeated m asure of NOVA analysis (group*time interaction).
Abbreviation: Total mastectomy it i lary lymph no e dissection; TM with ALND, Total mastec-
tomy with sentinel node biopsy; TM c SLNB, Partial mastectomy with axillary node dissection; PM
with ALND, Partial mastectomy with sentinel node biopsy; PM with SLNB, Postoperative day: POD.
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3.4. Change in Shoulder Function (from Pre-Surgery to 4-Week Post-Surgery)
On the affected arm, both shoulder ROM and strength scores significantly decreased
compared to their pre-surgery levels and did not fully recover until 4 weeks after surgery
(Table 4). On the unaffected arm, the ROM score only decreased on POD1 compared to its
pre-surgery level. Conversely, the shoulder strength of the unaffected arm significantly
reduced throughout the study period compared to its pre-surgery level. When shoulder
recovery patterns were analyzed by age, body mass index (BMI), and the number of lymph
nodes removed, recovery patterns did not differ by BMI and number lymph node recovery:
only age (under 55 age vs. over 55 age) showed a difference in the recovery of the ROM
score of the affected side (P for time = 0.04; Supplementary Figures S1 and S2).
The ROM score showed a different declining pattern on the affected arm according
to the surgical method. In terms of strength, a similar pattern of reduction was observed
regardless of the surgery method (Figure 3).
J. Clin. Med. 2021, 10, x FOR PEER REVIEW  10 of 14 
 
 
The ROM score showed a different declining pattern on the affected arm according 
to the surgical method. In terms of strength, a similar pattern of reduction was observed 
regardless of the surgery method (Figure 3).  
 
Figure 3. The changes in the shoulder function score in breast cancer patients after surgery accord-
ing to the surgery type (descriptive). P: the repeated measure of ANOVA analysis (group*time 
interaction). Abbreviation: Total mastectomy with axillary lymph node dissection; TM with 
ALND, Total mastectomy with sentinel node biopsy; TM c SLNB, Partial mastectomy with axillary 
node dissection; PM with ALND, Partial mastectomy with sentinel node biopsy; PM with SLNB, 
Postoperative day: POD. 
4. Discussion 
Previous studies have recommended early exercise intervention to alleviate shoulder 
discomfort and dysfunction related to breast cancer surgery. However, there is insuffi-
cient evidence of the extent of the recovery of shoulder ROM and strength during the early 
recovery phases, such as from immediately after surgery to until 4 weeks. Furthermore, 
shoulder recovery during the early recovery phase based on different breast cancer sur-
geries has not been studied. Therefore, we investigated shoulder ROM and strength after 
breast cancer surgery according to different surgical methods. We found a significant re-
duction in shoulder ROM immediately after surgery (36.7% reduction compared to base-
line), which recovered to up to 73.5% of the pre-surgery level. A significant reduction in 
shoulder ROM after 4 weeks was observed in patients regardless of the surgical method; 
however, patients who underwent TM with ALND seemed to have the most decreased 
shoulder ROM. Shoulder ROM on the unaffected side was also reduced when measured 
a day after surgery; however, this phenomenon was not observed 4 weeks after surgery. 
Similarly, we further noticed that shoulder strength was significantly decreased after sur-
gery (48.1% reduction compared to baseline), which recovered only up to 62.5% at 4 weeks 
after surgery. The degree of reduction in shoulder strength was similar regardless of the 
Figure 3. The changes in the shoulder function score in breast cancer patients after surgery according
to the surgery type (descriptive). P: the repeated measure of ANOVA analysis (group*time interac-
tion). Abbreviation: Total mastectomy with axillary lymph node dissection; TM with ALND, Total
mastectomy with sentinel node biopsy; TM c SLNB, Partial mastectomy with axillary node dissec-
ti n; PM with ALND, Partial mastectomy with sentinel node biopsy; PM with SLNB, Postoperative
day: POD.
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Table 4. Change of shoulder function score (pre-surgery to 4 weeks post-surgery).











Affected side (n = 30) 100.0 ± 0 63.3 ± 4.0 **+ 67.8 ± 2.4 **+ 70.5 ± 2.4 **+ 73.5 ± 2.6 **+ <0.001 <0.001 0.208 0.146 0.011
Unaffected side (n = 31) 100.0 ± 0 93.6 ± 2.4 * 97.9 ± 1.4 98.5 ± 1.5 100.4 ± 1.3 0.018 0.012 0.072 0.705 0.085
Strength score
Affected side (n = 31) 100.0 ± 0 52.9 ± 2.9 **+ 55.3 ± 2.2 **+ 61.8 ± 2.1 **+ 62.5 ± 2.3 **+ <0.001 <0.001 0.369 0.001 0.964
Unaffected side (n = 31) 100.0 ± 0 83.1 ± 2.3 ** 80.8 ± 2.8 ** 82.5 ± 2.4 ** 78.9 ± 2.9 ** <0.001 <0.001 0.335 0.461 0.035
Values are presented as mean ± standard error (SE), abbreviation: Postoperative Date; POD. P # represent overall differences according to time as determined using the repeated measures of ANOVA, * p < 0.01
vs. Baseline, ** p < 0.001 vs. Baseline, + p < 0.01 between the affected and unaffected side (POD1 to POD 24 adjusted for Baseline value).
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4. Discussion
Previous studies have recommended early exercise intervention to alleviate shoulder
discomfort and dysfunction related to breast cancer surgery. However, there is insufficient
evidence of the extent of the recovery of shoulder ROM and strength during the early recov-
ery phases, such as from immediately after surgery to until 4 weeks. Furthermore, shoulder
recovery during the early recovery phase based on different breast cancer surgeries has
not been studied. Therefore, we investigated shoulder ROM and strength after breast
cancer surgery according to different surgical methods. We found a significant reduction in
shoulder ROM immediately after surgery (36.7% reduction compared to baseline), which
recovered to up to 73.5% of the pre-surgery level. A significant reduction in shoulder
ROM after 4 weeks was observed in patients regardless of the surgical method; however,
patients who underwent TM with ALND seemed to have the most decreased shoulder
ROM. Shoulder ROM on the unaffected side was also reduced when measured a day after
surgery; however, this phenomenon was not observed 4 weeks after surgery. Similarly,
we further noticed that shoulder strength was significantly decreased after surgery (48.1%
reduction compared to baseline), which recovered only up to 62.5% at 4 weeks after surgery.
The degree of reduction in shoulder strength was similar regardless of the surgical method.
Unlike shoulder ROM, a significant decrease in shoulder strength was also observed in the
unaffected arm at 4 weeks after surgery (78.9% compared to baseline).
Within the first month after breast cancer surgery, patients experienced the greatest
change in ROM. In this study, we found a 36.7% reduction in shoulder ROM at POD1,
which recovered to up to 73.5% of the pre-surgery levels at 1 month after surgery. In
contrast, the ROM of the unaffected arm was significantly reduced on POD1 and recovered
fully by POD10. The significant reduction in shoulder ROM at 1 month after surgery
observed in our study agrees with a previously reported study. Springer et al. reported
that shoulder ROM recovered to up to about 93% of baseline. They further observed that
participants’ shoulder ROM recovered to the pre-surgery level at 1 year after surgery [16].
Cinar et al. [17] reported a significant reduction in shoulder ROM on the fifth day after
surgery (treatment group: flexion 74.7%, abduction 64.6% of baseline; home exercise
program group: flexion 60.5%, abduction 53.5% of baseline), which did not fully recover
until 1 month after surgery (treatment group: flexion 95.8%, abduction 93.4% of baseline;
home exercise program group: flexion 76.5%, abduction 69.4% of baseline). In our study,
the ROM of the unaffected arm showed a reduction on POD1, which had almost recovered
to the baseline level on POD10.
We further studied whether the recovery of shoulder ROM differs according to the
surgical method. As expected, patients who underwent PM with SLNB seemed to recover
their shoulder ROM better than those who underwent other methods of surgery, such as
TM with ALND. Nesvold et al. [18] reported that impaired shoulder flexion (by ≥25◦ of
the unaffected arm) was observed in 24% of patients who underwent radical modified
mastectomy and 7% of those who underwent breast-conserving surgery. Compared to
breast-conserving surgery, mastectomy significantly increased the risk of impaired shoulder
ROM in flexion and abduction by 3.3 (OR 3.3, 95% CI 1.2–9.14; p = 0.02) and 2.3 (OR 2.3,
95% CI 1.06–4.98; p = 0.04) times, respectively. Participants who underwent ALND showed
a considerable loss of shoulder ROM compared to the SLNB group, even after several years
post-surgery [9,19].
There are a few studies which have observed the change in shoulder strength after
breast cancer surgery. Belmonte et al. [20] reported significant reduction in shoulder
strength in both the affected and unaffected arm 5 years post-surgery. Klassen et al. [21]
also observed 12–16% lower shoulder strength among breast cancer patients during cancer
treatments (e.g., surgery, chemotherapy, radiation, etc.). However, both studies observed
changes in shoulder strength among breast cancer patients from a few months to a few
years after breast cancer surgery, with changes immediately after surgery being absent.
In our study, a significant reduction in shoulder strength was found in both the affected
and unaffected arms immediately after surgery, which did not recover up to four weeks.
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Interestingly, shoulder strength was significantly reduced in not only the affected arm but
also the unaffected arm, although the pattern of decline in shoulder strength differed. The
strength of the affected arm decreased immediately after surgery and recovered only up to
52.9% of the pre-surgery level, while the strength of the unaffected arm gradually declined
over 4 weeks.
We noticed that shoulder strength significantly decreased after surgery regardless of
the surgical method; these results differ from those of previous studies. Belmonte et al. [20]
and Sagen et al. [9] reported that participants who underwent ALND showed a slower
recovery of shoulder strength than those who underwent SLNB. The reason why we did
not observe differences in our participants’ shoulder strength recovery after surgery is
unclear. It may be due to the lack of upper body use after surgery or to the relatively short
follow-up duration in our participants. We followed up our participants for up to 4 weeks
only, whereas other studies followed up their participants’ shoulder strength recovery up
to several years [9,19,22]. If we had performed a longer follow-up of shoulder strength in
our participants, we may have observed different shoulder strength recoveries based on
the surgical methods.
The reduction in shoulder strength regardless of surgical methods (whether they
are more invasive, which may cause more damages in muscles and facia, or less inva-
sive, which may cause only a small or no damage in the muscles and facia) is of interest.
In general, upper limb problems, including reduction in shoulder strength after mastec-
tomy or axillary surgery, can cause lymphedema, shoulder restriction, pain, numbness,
and weakness [22–24]. In the process of healing, damaged tissue and fascia could be-
come shorter than their lengths before surgery, leading to limitations in shoulder move-
ment [24,25]. Additionally, surgery carries the risk of causing nerve injury (involving the
intercostobrachial nerve or long thoracic nerve), which can lead to sensation changes or
chronic pain in the surgical area [26].
As mentioned above, a gradual reduction in shoulder strength on the unaffected
side is an interesting finding. Theoretically, there is no anatomical and physiological
reason for this reduction in strength over time. However, breast cancer patients seemed
to be discouraged to use their upper body, including both the affected and unaffected
sides. Therefore, reduction in shoulder strength could be due to both lack of use and the
results of surgery, such as anatomical damage of muscle, facia, and skin. About 70% of
breast cancer patients showed avoidance of strenuous arm activity after surgery, and the
primary reasons were pain, scar formation, swelling and considerable fear of lymphedema,
misinterpretation of arm care advice, and low coping ability [27]. In addition, patients who
avoided using their arms reported more arm and chest symptoms than those who did not
avoid using their upper limbs [27]. Patients experiencing pain after surgery may tend to
adopt protective postures such as dropped and rounded shoulder and arm, in addition to
reduced use of the arm. This results in long-term changes to muscle length and activity [28].
The various physical and psychological effects of surgery can also impede the return to
activities of daily living and increase long-term stress [20,29].
This study had some limitations. First, the sample size was small and, therefore, it is
difficult to generalize our results. Second, more than 80% of participants were less than
60 years of age and, therefore, our results may not be generalizable to older breast cancer
patients (>60 years). Third, when we measured ROM and strength, participants’ shoulder
problems before surgery and physical activities after surgery were not controlled. Despite
these limitations, we believe that the current study has important clinical implications for
understanding the patterns of shoulder function, including shoulder ROM and strength, in
the early recovery phase in post-surgery breast cancer patients.
The main finding of this study indicates that shoulder ROM and strength decreased in
postoperative breast cancer patients. The reduction in shoulder ROM was observed after
surgery, especially so on the affected arm rather than the unaffected arm. The shoulder
strength was reduced in both the affected and unaffected sides after surgery. The recovery
of ROM showed different patterns depending on the surgical method; however, the strength
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of the shoulder showed a similar pattern of decrease regardless of the surgical methods.
The results of this study suggest the need for early rehabilitation after breast cancer surgery.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/jcm10153416/s1, Figure S1: The changes in the shoulder ROM score in breast cancer patients
after surgery according to subgroup (descriptive), Figure S2: The changes in the shoulder strength
score in breast cancer patients after surgery according to subgroup (descriptive).
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